Start the conversation
Back about a year and a half ago, I told you about a tech stock that would allow you to "laugh at the next big sell-off."
And, well, since then, the market has been no joke. In fact, it's been absolutely turbulent - including last month's big sell-off.
The Standard & Poor's 500 Index is down by roughly 5% so far this year - while the tech stock I recommend back then is at breakeven. That means its shares have crushed the overall market by some 35% since I first recommended it.
And now Wall Street is waking up to the incredible value in this diversified tech play.
Indeed, The Wall Street Journal ran a story Sept. 2 touting one of the main points I made to you some 18 months ago - that this company is one of the nation's top M&A engines.
So, today I want to let you know which company I'm talking about - and why now is not too late to invest...
Still the "Leader of the Pack"
When I first recommended it March 14, 2014, I was one of the first tech analysts to note that Honeywell International Inc. (NYSE: HON) boasts a very impressive M&A team, led by Chief Executive David Cote.
I listed its acquiring nature as a catalyst for the stock and a prime reason to invest. "When it comes to the tech sector's version of 'Let's Make a Deal,' Honeywell intends to be the 'Leader of the Pack' in this realm," I said at the time.
The company had recently disclosed it had amassed a $10 billion war chest for filling out the franchise through 2018.
That was more than twice the amount it had spent on M&A in the five years leading up to that point. And with just that that dynamic in place, the stock skyrocketed 290% from March 2009 to March 2014 and outpaced the S&P 500 by nearly 86% at the time.
So shareholders are in favor of Honeywell's shopping sprees. They want to see the company continue making these big acquisitions and diversifying its offerings. But they want to see it done at little to no risk.
That was my point 18 months ago - and out almost exactly the same argument The Wall Street Journal made in its recent story.
In other words, Honeywell meets something of an inverse of Rule No. 2 of Your Tech Wealth Blueprint. That rule says to "separate the signal from the noise." To create real wealth, you have to ignore not only the hype you get from companies, but also the noise you hear on Wall Street.
However, in this case, there was no "noise" from the Street - analysts had yet to put the Honeywell puzzle pieces together.
But that's changing, starting with the Journal's recent flattering profile.
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.